Inagaki Emi, Yoshimatsu Sho, Okano Hideyuki
Department of Physiology, Keio University School of Medicine, Tokyo, Japan.
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Front Aging Neurosci. 2022 Aug 9;14:868770. doi: 10.3389/fnagi.2022.868770. eCollection 2022.
In developed countries, the aging of the population and the associated increase in age-related diseases are causing major unresolved medical, social, and environmental matters. Therefore, research on aging has become one of the most important and urgent issues in life sciences. If the molecular mechanisms of the onset and progression of neurodegenerative diseases are elucidated, we can expect to develop disease-modifying methods to prevent neurodegeneration itself. Since the discovery of induced pluripotent stem cells (iPSCs), there has been an explosion of disease models using disease-specific iPSCs derived from patient-derived somatic cells. By inducing the differentiation of iPSCs into neurons, disease models that reflect the patient-derived pathology can be reproduced in culture dishes, and are playing an active role in elucidating new pathological mechanisms and as a platform for new drug discovery. At the same time, however, we are faced with a new problem: how to recapitulate aging in culture dishes. It has been pointed out that cells differentiated from pluripotent stem cells are juvenile, retain embryonic traits, and may not be fully mature. Therefore, attempts are being made to induce cell maturation, senescence, and stress signals through culture conditions. It has also been reported that direct conversion of fibroblasts into neurons can reproduce human neurons with an aged phenotype. Here, we outline some state-of-the-art insights into models of neuronal aging . New frontiers in which stem cells and methods for inducing differentiation of tissue regeneration can be applied to aging research are just now approaching, and we need to keep a close eye on them. These models are forefront and intended to advance our knowledge of the molecular mechanisms of aging and contribute to the development of novel therapies for human neurodegenerative diseases associated with aging.
在发达国家,人口老龄化以及与之相关的年龄相关性疾病的增加正引发重大且尚未解决的医学、社会和环境问题。因此,衰老研究已成为生命科学中最重要且最紧迫的问题之一。如果能够阐明神经退行性疾病发生和发展的分子机制,我们有望开发出改变疾病进程的方法来预防神经退行性变本身。自从诱导多能干细胞(iPSC)被发现以来,利用源自患者体细胞的疾病特异性iPSC构建的疾病模型如雨后春笋般涌现。通过诱导iPSC分化为神经元,可以在培养皿中重现反映患者病理特征的疾病模型,这些模型在阐明新的病理机制以及作为新药研发平台方面发挥着积极作用。然而,与此同时,我们面临着一个新问题:如何在培养皿中模拟衰老过程。有人指出,从多能干细胞分化而来的细胞较为幼稚,保留着胚胎特征,可能并未完全成熟。因此,人们正在尝试通过培养条件诱导细胞成熟、衰老和应激信号。也有报道称,将成纤维细胞直接转化为神经元可以重现具有衰老表型的人类神经元。在此,我们概述一些关于神经元衰老模型的最新见解。干细胞和组织再生诱导分化方法可应用于衰老研究的新前沿刚刚崭露头角,我们需要密切关注。这些模型处于前沿水平,旨在增进我们对衰老分子机制的了解,并为与衰老相关的人类神经退行性疾病的新疗法开发做出贡献。